NOVILYTIC, LLC
Continuous upstream process monitoring system that automatically detects and quantifies monoclonal antibody proteoform variants during fermentation using parallel analytical engines with mass spectrom
- Sector
- Biotech
- Headquarters
- North Webster, IN
- Latest Form D
- $531K, Dec 2025
- Total capital
- $6.7M
- Federal grants
- $5.2M
- 7 awards · 2015–2021
- Rank in peer group#12 of 42
- Private capital raised
- $1.5M
- 2 Form D · last Dec 2025
- 10 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 5
- 10 pending · first 2015
- Rank in peer group#7 of 42
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$531K
- Federal grantHealth and Human S · Phase II · The PROTEOMETER; A Continuous Upstream Process Monitoring Engine$738K
- Private capital raisedForm D · SEC · 1st filing$950K
- Federal grantHealth and Human S · Phase II · The PROTEOMETER; A Continuous Upstream Process Monitoring Engine$1.4M
- Federal grantHealth and Human S · Phase II · SAMPLE PREPARATION; The Achilles Heel of Mass Spectrometry Based Diagnostics II.$93K
- Federal grantHealth and Human S · Phase II · SAMPLE PREPARATION; The Achilles Heel of Mass Spectrometry Based Diagnostics II.$750K
- Federal grantHealth and Human S · Phase II · SAMPLE PREPARATION; The Achilles Heel of Mass Spectrometry Based Diagnostics II.$1.6M
Show 2 earlier federal awards
- Federal grantHealth and Human S · Phase I · SAMPLE PREPARATION; The Achilles Heel of Mass Spectrometry Based Diagnostics$147K
- Federal grantHealth and Human S · Phase II · A New Method For The Analysis Of Vitamin D$480K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
68months
from NOVILYTIC, LLC’s first federal award to its first private round.
- First federal award · Jul 2015
- Health and Human S · $480K
- First Form D · Apr 2021
- $950K · 1st Form D
- Awards before first raise
- 6 awards
An association in public records, not a cause or a prediction.
Standing among 42 peers
Line = medianBiotech · Instrument
- Federal grants#12 · top 29%
- Granted patents#7 · top 17%
- Linked publications#1 · top 2%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Fred E RegnierResearcherExecutive Officer, DirectorLinked by 5 patents · $3.2M in grants as PI
- Alan E SymonsDirectorNamed in SEC Form D filings
- Edward W WoenkerDirectorNamed in SEC Form D filings
- Jiri AdamecDirectorNamed in SEC Form D filings
- Johnston C ErwinDirectorNamed in SEC Form D filings
- Jonathan C EdwardsenDirectorNamed in SEC Form D filings
Show all 9 people
- Paul C DreierExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Rich E WynneExecutive OfficerNamed in SEC Form D filings
- Timothy WoenkerDirectorNamed in SEC Form D filings
What it has protected
USPTO · 5 granted of 15- PendingMolecular Recogntion Assays Of Critical Structure Attributes In ProteoformsUSPTOApplication 19436020
- GrantedMolecular Recogntion Assays Of Critical Structure Attributes In ProteoformsUSPTOUS 12,510,546
- PendingProteoform Specific Process ValidationUSPTOApplication 19285621
Show all 15 patent records
- Molecular Recogntion Assays Of Critical Structure Attributes In ProteoformsMay 7, 2026 · Application 19436020Pending
- Molecular Recogntion Assays Of Critical Structure Attributes In ProteoformsDec 30, 2025 · US 12,510,546Granted
- Proteoform Specific Process ValidationNov 20, 2025 · Application 19285621Pending
- Analytical Platform for Biological Function Appraisal in Recombinant Therapeutic ProteinsAug 7, 2025 · Application 19043500Pending
- Proteoform Specific Process ValidationAug 5, 2025 · US 12,379,383Granted
- Method for Analyzing Samples of Biological Fluid and Apparatus for Performing the SameMay 7, 2019 · US 10,281,474Granted
- Method for Analyzing Samples of a Biological FluidJul 10, 2018 · US 10,018,635Granted
- Apparatus for Multiplex Extraction of Biological Samples and In-Transit Preparation of the SameMar 31, 2016 · Application 14867722Pending
- Method for Determining Derivatized Analytes in A Separated Biological FluidJun 30, 2015 · US 9,068,995Granted
- Proteoform Specific Process ValidationApplication PCTUS2021050616Pending
- Apparatus For Multiplex Extraction Of Biological Samples And In-transit Preparation Of The SameApplication PCTUS2015052641Pending
- Molecular Recognition Assays Of Critical Structure Attributes In ProteoformsApplication PCTUS2023081391Pending
- Method For Analyzing Samples Of Biological Fluid And Apparatus For Performing The SameApplication PCTUS2015042952Pending
- Method For Determining Derivatized Analytes In A Separated Biological FluidApplication PCTUS2014027410Pending
- Performance Appraisal of Recombinant Therapeutic ProteinsApplication 63548941Pending
Recent research by its founders
- Factors Associated With Failure to Obtain Induced Sputum Samples in Asthmatic Patients20250 cites
- Mobile Affinity Selection Chromatography Analysis of Therapeutic Monoclonal Antibodies20234 cites
- Affinity-targeting schemes for protein biomarkers20191 cites
Related companies, and why
- BasisSimilar federal contract value in Biotech · null in contracts
- SHIFA BIOMEDICAL CORPORATIONSimilar federal contract value in Biotech · null in contracts
- MDI THERAPEUTICS INCSimilar federal contract value in Biotech · null in contracts
- OPTIKIRA, LLCSimilar federal contract value in Biotech · null in contracts
- AMERICAN LIFE SCIENCE PHARMACEUTICALS, INC.Similar federal contract value in Biotech · null in contracts
- 7 Hills Pharma LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .